Compare SERV & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SERV | INMD |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 913.2M | 879.2M |
| IPO Year | N/A | 2019 |
| Metric | SERV | INMD |
|---|---|---|
| Price | $9.41 | $14.34 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 6 |
| Target Price | ★ $18.80 | $16.75 |
| AVG Volume (30 Days) | ★ 6.1M | 1.3M |
| Earning Date | 03-05-2026 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.43 |
| Revenue | $1,944,483.00 | ★ $370,495,000.00 |
| Revenue This Year | $41.13 | $5.40 |
| Revenue Next Year | $908.17 | $4.80 |
| P/E Ratio | ★ N/A | $9.96 |
| Revenue Growth | ★ 15.76 | N/A |
| 52 Week Low | $4.66 | $13.14 |
| 52 Week High | $23.10 | $19.78 |
| Indicator | SERV | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.13 | 45.03 |
| Support Level | $9.08 | $14.19 |
| Resistance Level | $11.36 | $15.39 |
| Average True Range (ATR) | 0.93 | 0.57 |
| MACD | -0.24 | -0.12 |
| Stochastic Oscillator | 9.67 | 7.46 |
Serve Robotics Inc is developing next-generation robots for last-mile delivery services. It design, develop and operate low-emissions robots on AI-powered robotics mobility platform, that serve people in public spaces, starting with food delivery. Its first product is a zero-emission robot that serves people in public areas, Starting with food delivery. It has developed an AI-robotics mobility platform, with last-mile delivery in cities as its first application.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.